Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular edema ...

Discover how a new eye drop treatment may prevent the loss of vision associated with dry age-related macular degeneration, ...

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

Regeneron has scooped up Oxular, a retinal-disease-focused company based in the U.K., closing the deal at the very end of ...

Age-related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...

Articles covering FDA approvals, dry eye disease, and how eye diseases may be linked to falls were among the top 5 most-read ...

Sigma-2 receptor modulation using exogenous ligands reduces cellular damage associated with central nervous system degeneration in age-related pathologies such as Alzheimer’s disease, Parkinson’s ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Eculizumab is under clinical development by Alexion Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury.